Anthony James Barkovich

Anthony James Barkovich

Auto-generated profile, based on publicly available information

Anthony James Barkovich

Neuroradiology Section, Department of Radiology and Biomedical Imaging, UCSF-Benioff Children's Hospital, San Francisco, Q6 CA, United States

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 March 2012 in Brain
Verified
Journal Article
Open access
PDF file
ABA. James Barkovich
A. James Barkovich
RGRenzo Guerrini
Renzo Guerrini
RKRuben I. Kuzniecky
Ruben I. Kuzniecky
GJGraeme D. Jackson
Graeme D. Jackson
WDWilliam B. Dobyns
William B. Dobyns
Malformations of cerebral cortical development include a wide range of developmental disorders that are common causes of neurodevelopmental delay and epilepsy. In addition, study of these disorders contributes greatly to the understanding of normal brain development and its perturbations. The rapid recent evolution of molecular biology, genetics and imaging has resulted in an explosive increase in our knowledge of cerebral cortex development and in the number and types of malformations of cortical development that have been reported. These advances continue to modify our perception of these malformations. This review addresses recent changes in our perception of these disorders and proposes a modified classification based upon updates in our knowledge of cerebral cortical development.

1 January 1998
Verified
Journal Article
Closed access
ABA J Barkovich
A J Barkovich
BHB L Hajnal
B L Hajnal
DVD Vigneron
D Vigneron
ASA Sola
A Sola
JPJ C Partridge
J C Partridge
Donna FerrieroDonna Ferriero
Donna Ferriero

1 May 2015 in Cold Spring Harbor Perspectives in Medicine
Verified
Journal Article
Open access
PDF file
ABA. James Barkovich
A. James Barkovich
WDWilliam B. Dobyns
William B. Dobyns
RGRenzo Guerrini
Renzo Guerrini
Malformations of cortical development (MCDs) are an important cause of epilepsy and an extremely interesting group of disorders from the perspective of brain development and its perturbations. Many new MCDs have been described in recent years as a result of improvements in imaging, genetic testing, and understanding of the effects of mutations on the ability of their protein products to correctly function within the molecular pathways by which the brain functions. In this review, most of the major MCDs are reviewed from a clinical, embryological, and genetic perspective. The most recent literature regarding clinical diagnosis, mechanisms of development, and future paths of research are discussed.

11 June 2014 in Annals of Neurology
Verified
Journal Article
Open access
PDF file
PPPetra J. W. Pouwels
Petra J. W. Pouwels
AVAdeline Vanderver
Adeline Vanderver
GBGenevieve Bernard
Genevieve Bernard
NWNicole Wolf
Nicole Wolf
SDSteffi F. Dreha‐Kulczewksi
Steffi F. Dreha‐Kulczewksi
ABA. James Barkovich
A. James Barkovich
Hypomyelinating leukodystrophies represent a genetically heterogeneous but clinically overlapping group of heritable disorders. Current management approaches in the care of the patient with a hypomyelinating leukodystrophy include use of serial magnetic resonance imaging (MRI) to establish and monitor hypomyelination, molecular diagnostics to determine a specific etiology, and equally importantly, careful attention to neurologic complications over time. Emerging research in oligodendrocyte biology and neuroradiology with bedside applications may result in the possibility of clinical trials in the near term, yet there are significant gaps in knowledge in disease classification, characterization, and outcome measures in this group of disorders. Here we review the biological background of myelination, the clinical and genetic variability in hypomyelinating leukodystrophies, and the insights that can be obtained from current MRI techniques. In addition, we discuss ongoing research approaches to define potential outcome markers for future clinical trials. Ann Neurol 2014;76:5–19

11 November 2016 in Annals of Neurology
Verified
Journal Article
Closed access
PDF file
RDRahul S. Desikan
Rahul S. Desikan
ABA. James Barkovich
A. James Barkovich

5 October 2017 in American Journal of Neuroradiology
Verified
Journal Article
Open access
PDF file
MWMax Wintermark
Max Wintermark
NHN.K. Hills
N.K. Hills
GDG.A. DeVeber
G.A. DeVeber
ABA.J. Barkovich
A.J. Barkovich
TBT.J. Bernard
T.J. Bernard
TIthe VIPS Investigators
the VIPS Investigators
BACKGROUND AND PURPOSE: Childhood arteriopathies are rare but heterogenous, and difficult to diagnose and classify, especially by nonexperts. We quantified clinical and imaging characteristics associated with childhood arteriopathy subtypes to facilitate their diagnosis and classification in research and clinical settings. MATERIALS AND METHODS: The Vascular Effects of Infection in Pediatric Stroke (VIPS) study prospectively enrolled 355 children with arterial ischemic stroke (2010–2014). A central team of experts reviewed all data to diagnose childhood arteriopathy and classify subtypes, including arterial dissection and focal cerebral arteriopathy–inflammatory type, which includes transient cerebral arteriopathy, Moyamoya disease, and diffuse/multifocal vasculitis. Only children whose stroke etiology could be conclusively diagnosed were included in these analyses. We constructed logistic regression models to identify characteristics associated with each arteriopathy subtype. RESULTS: Among 127 children with definite arteriopathy, the arteriopathy subtype could not be classified in 18 (14%). Moyamoya disease (n = 34) occurred mostly in children younger than 8 years of age; focal cerebral arteriopathy–inflammatory type (n = 25), in children 8–15 years of age; and dissection (n = 26), at all ages. Vertigo at stroke presentation was common in dissection. Dissection affected the cervical arteries, while Moyamoya disease involved the supraclinoid internal carotid arteries. A banded appearance of the M1 segment of the middle cerebral artery was pathognomonic of focal cerebral arteriopathy–inflammatory type but was present in <25% of patients with focal cerebral arteriopathy–inflammatory type; a small lenticulostriate distribution infarct was a more common predictor of focal cerebral arteriopathy–inflammatory type, present in 76%. It remained difficult to distinguish focal cerebral arteriopathy–inflammatory type from intracranial dissection of the anterior circulation. We observed only secondary forms of diffuse/multifocal vasculitis, mostly due to meningitis. CONCLUSIONS: Childhood arteriopathy subtypes have some typical features that aid diagnosis. Better imaging methods, including vessel wall imaging, are needed for improved classification of focal cerebral arteriopathy of childhood.